• -50%
Zwitserse Apotheek|Agyrax 25 mg tabl. 50|Vomit
Zwitserse Apotheek|Agyrax 25 mg tabl. 50|Vomit
Zwitserse Apotheek|Agyrax 25 mg tabl. 50|Vomit
Zwitserse Apotheek|Agyrax 25 mg tabl. 50|Vomit

Agyrax 25 mg tabl. 50

AXONE PHARMA.
0615203
€7.51 €15.02 -50%

€7.08 tax excluded

Tax included

Prevention and symptomatic treatment of nausea, vomiting, and dizziness associated with motion sickness.  currenty expiry date: 31th of January 2027

 

- Prevention and symptomatic treatment of nausea, vomiting, and dizziness associated with motion sickness. currenty expiry date: 31th of January 2027

Brands
Pierre Fabre.
Delivery form
Tablet.
Type of product
Spécialité
Couleur
White
0615203
No reviews

ADULTS AND CHILDREN FROM 12 YEARS:
- 25 to 50 mg taken 1 hour before departure. Renew every 24 hours during the journey dose.
- Dose adjustments identified in the elderly.

What Agyrax contains

  • The active ingredient is meclozine. Each Agyrax 25 mg tablet contains 25 mg of meclozine hydrochloride.

  • The other ingredients are: highly dispersed silicon dioxide – maize starch – calcium stearate

  • Lactose - Talc - Polyvidon K 30.

This is a medecine available without a prescription.. Do not use long without medical advice. Read the instructions carefully. Keep this medicine out of the reach of children. Keep the manual as it contains important information. Ask for advice from your doctor or pharmacist. Consult your doctor if adverse reactions.

'

This is a medecine available without a prescription.. Do not use long without medical advice. Read the instructions carefully. Keep this medicine out of the reach of children. Keep the manual as it contains important information. Ask for advice from your doctor or pharmacist. Consult your doctor if adverse reactions.

'

Customers who bought this product also bought:

6 other products in the same category:

Product added to wishlist
Product added to compare.

We use cookies to provide you with the best possible service. By visiting our website you agree to the placing of cookies.